0001140361-22-045704.txt : 20221215 0001140361-22-045704.hdr.sgml : 20221215 20221215164536 ACCESSION NUMBER: 0001140361-22-045704 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221121 FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lea Darrell Shane CENTRAL INDEX KEY: 0001958526 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36598 FILM NUMBER: 221465389 MAIL ADDRESS: STREET 1: 7 PARKLAND DRIVE CITY: MILFORD STATE: NJ ZIP: 08848 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectar Biosciences, Inc. CENTRAL INDEX KEY: 0001279704 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043321804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (608) 441-8120 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050617 FORMER COMPANY: FORMER CONFORMED NAME: COMMON HORIZONS INC DATE OF NAME CHANGE: 20040211 3 1 form3.xml X0206 3 2022-11-21 1 0001279704 Cellectar Biosciences, Inc. CLRB 0001958526 Lea Darrell Shane C/O CELLECTAR BIOSCIENCES, INC. 100 CAMPUS DRIVE FLORHAM NJ 07932 true Chief Commercial Officer Exhibit 24 - Power of Attorney /s/ Christina Blakley, Attorney-in-fact for Darrell Shane Lea 2022-12-15 EX-24 2 brhc10045490_ex24.htm EXHIBIT 24
Exhibit 24

CONFIRMING STATEMENT

This Statement confirms that the undersigned has authorized and designated Asher M. Rubin, Istvan Hajdu, Andrea Reed, and Christina Blakley, each acting singly, to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Cellectar Biosciences, Inc.  The authority of Asher M. Rubin, Istvan Hajdu, Andrea Reed, and Christina Blakley under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of Cellectar Biosciences, Inc. unless earlier revoked in writing.  The undersigned acknowledges that Asher M. Rubin, Istvan Hajdu, Andrea Reed, and Christina Blakley are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Statement revokes the authority of any person named in any prior confirming statement relating to the undersigned's filing obligations with respect to securities of Cellectar Biosciences, Inc. who is not named herein, and this Statement replaces and supersedes any such prior confirming statement.

Dated: December 9, 2022
Signed: /s/ D. Shane Lea
   
 
Print Name: D. Shane Lea